DEERFIELD MANAGEMENT COMPANY, L.P. Q2 2021 Filing
Filed August 16, 2021
Portfolio Value
$5.6B
Holdings
143
Report Date
Q2 2021
Filing Type
13F-HR
All Holdings (143 positions)
| # | Stock | Shares | Value | % Portfolio | Type |
|---|---|---|---|---|---|
| 101 | ANNXANNEXON INC | 583,913 | $13.1B | 233.48% | |
| 102 | COGTCOGENT BIOSCIENCES INC | 1,601,000 | $13.0B | 230.64% | |
| 103 | BDTXBLACK DIAMOND THERAPEUTICS I | 1,047,599 | $12.8B | 226.83% | |
| 104 | —CONVEY HLDG PARENT INC | 1,100,000 | $12.5B | 222.36% | |
| 105 | AMWLAMERICAN WELL CORP | 991,115 | $12.5B | 221.47% | |
| 106 | AGLAGILON HEALTH INC | 300,000 | $12.2B | 216.19% | |
| 107 | GHRSGH RESEARCH PLC | 555,416 | $12.1B | 214.38% | |
| 108 | CVRXCVRX INC | 400,000 | $11.2B | 198.95% | |
| 109 | LFSTLIFESTANCE HEALTH GROUP INC | 400,000 | $11.1B | 197.95% | |
| 110 | —SARISSA CAPITAL ACQUISITN CO | 1,000,000 | $10.4B | 185.09% | |
| 111 | BCABBIOATLA INC | 245,381 | $10.4B | 184.72% | |
| 112 | —EUCRATES BIOMEDICAL ACQU COR | 1,000,000 | $10.2B | 181.18% | |
| 113 | —SENIOR CONNECT ACQUISITN COR | 1,000,000 | $10.1B | 179.76% | |
| 114 | —REVOLUTION HEALTHCAR AQ CORP | 1,000,000 | $10.1B | 179.05% | |
| 115 | —MEDTECH ACQUISITION CORP | 1,000,000 | $10.0B | 177.99% | |
| 116 | ADVMCHFADVERUM BIOTECHNOLOGIES INC | 2,827,000 | $9.9B | 175.77% | |
| 117 | —CM LIFE SCIENCES II INC | 600,000 | $8.1B | 143.35% | |
| 118 | GLUEMONTE ROSA THERAPEUTICS INC | 350,000 | $7.9B | 141.13% | |
| 119 | OKURRENEO PHARMACEUTICALS INC | 849,300 | $7.9B | 140.75% | |
| 120 | OLMAOLEMA PHARMACEUTICALS INC | 271,191 | $7.6B | 134.79% | |
| 121 | —TURMERIC ACQUISITION CORP | 750,000 | $7.5B | 134.02% | |
| 122 | —IGNYTE ACQUISITION CORP | 725,000 | $7.3B | 129.05% | |
| 123 | —TURNING POINT THERAPEUTICS I | 83,846 | $6.5B | 116.21% | |
| 124 | DCTHDELCATH SYS INC | 500,000 | $6.3B | 112.00% | |
| 125 | TALKTALKSPACE INC | 750,000 | $6.2B | 110.72% | |
| 126 | BNFT 1.25 12/15/23BENEFITFOCUS INC | 6,500,000 | $6.1B | 108.89% | |
| 127 | IM8NINSMED INC | 200,000 | $5.7B | 101.11% | |
| 128 | —CONSONANCE HFW ACQUISITION C | 500,000 | $5.2B | 92.37% | |
| 129 | —ORION ACQUISITION CORP | 500,000 | $5.0B | 88.10% | |
| 130 | —INTERSECT ENT INC | 255,456 | $4.4B | 77.55% | |
| 131 | CABACABALETTA BIO INC | 464,252 | $4.0B | 70.93% | |
| 132 | BMEABIOMEA FUSION INC | 248,447 | $3.9B | 68.89% | |
| 133 | BFLYWBUTTERFLY NETWORK INC | 733,333 | $3.5B | 62.92% | |
| 134 | —CAREMAX INC | 672,000 | $3.2B | 56.34% | |
| 135 | 698ACHILLES THERAPEUTICS PLC | 301,431 | $3.0B | 52.42% | |
| 136 | NEO 0.25 01/15/28NEOGENOMICS INC | 2,500,000 | $2.5B | 43.55% | |
| 137 | —CEREVEL THERAPEUTICS HLDNG I | 166,666 | $2.4B | 42.60% | |
| 138 | —DFP HEALTHCARE ACQUISITNS CO | 1,250,000 | $2.2B | 38.42% | |
| 139 | QSIAWQUANTUM SI INC | 333,333 | $1.3B | 22.26% | |
| 140 | —METACRINE INC | 277,469 | $1.1B | 18.72% | |
| 141 | NUVB/WSNUVATION BIO INC | 166,666 | $433.0M | 7.69% | |
| 142 | 4NX1LUMOS PHARMA INC | 33,117 | $331.0M | 5.88% | |
| 143 | WINTWINDTREE THERAPEUTICS INC | 20,148 | $46.0M | 0.82% |
PreviousPage 2 of 2